5AM Venture Management as of Sept. 30, 2024
Portfolio Holdings for 5AM Venture Management
5AM Venture Management holds 28 positions in its portfolio as reported in the September 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Entrada Therapeutics (TRDA) | 14.6 | $70M | 4.4M | 15.98 | |
Enliven Therapeutics (ELVN) | 9.2 | $45M | 1.8M | 25.54 | |
Skye Bioscience Com New (SKYE) | 8.0 | $39M | 9.9M | 3.91 | |
Artiva Biotherapeutics | 7.5 | $36M | 2.4M | 15.45 | |
Dianthus Therapeutics (DNTH) | 7.0 | $34M | 1.2M | 27.38 | |
Biohaven (BHVN) | 4.9 | $24M | 479k | 49.97 | |
Tyra Biosciences (TYRA) | 4.6 | $22M | 939k | 23.51 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 4.2 | $21M | 1.3M | 15.99 | |
Tectonic Therapeutic (TECX) | 4.0 | $20M | 647k | 30.30 | |
Praxis Precision Medicines I Com New (PRAX) | 4.0 | $20M | 340k | 57.54 | |
Celldex Therapeutics Com New (CLDX) | 3.5 | $17M | 497k | 33.99 | |
Miragen Therapeutics (VRDN) | 3.5 | $17M | 737k | 22.75 | |
Viking Therapeutics (VKTX) | 3.1 | $15M | 238k | 63.31 | |
Pharvaris N V (PHVS) | 3.1 | $15M | 798k | 18.52 | |
Erasca (ERAS) | 3.0 | $15M | 5.4M | 2.73 | |
Moonlake Immunotherapeutics Class A Ord (MLTX) | 2.9 | $14M | 282k | 50.42 | |
Anaptysbio Inc Common (ANAB) | 2.5 | $12M | 358k | 33.50 | |
Silence Therapeutics Ads (SLN) | 1.8 | $8.7M | 476k | 18.18 | |
Eyepoint Pharmaceuticals Com New (EYPT) | 1.7 | $8.4M | 1.1M | 7.99 | |
Cogent Biosciences (COGT) | 1.3 | $6.1M | 562k | 10.80 | |
Scpharmaceuticals (SCPH) | 1.1 | $5.5M | 1.2M | 4.56 | |
Vor Biopharma (VOR) | 0.9 | $4.5M | 6.4M | 0.70 | |
Rallybio Corp (RLYB) | 0.9 | $4.2M | 3.6M | 1.17 | |
Gh Research Ordinary Shares (GHRS) | 0.8 | $3.8M | 573k | 6.69 | |
Adverum Biotechnologies Com New (ADVM) | 0.8 | $3.8M | 542k | 7.02 | |
Mersana Therapeutics (MRSN) | 0.5 | $2.5M | 1.3M | 1.89 | |
Zentalis Pharmaceuticals (ZNTL) | 0.4 | $1.8M | 490k | 3.68 | |
Cidara Therapeutics Com New (CDTX) | 0.1 | $610k | 57k | 10.75 |